These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32423949)

  • 1. Extended-Spectrum-β-Lactamase- and Plasmid AmpC-Producing Escherichia coli Causing Community-Onset Bloodstream Infection: Association of Bacterial Clones and Virulence Genes with Septic Shock, Source of Infection, and Recurrence.
    Fröding I; Hasan B; Sylvin I; Coorens M; Nauclér P; Giske CG
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of extended-spectrum β-lactamase/plasmid AmpC-β-lactamase-producing Escherichia coli isolates from long-term recurrent bloodstream infections.
    Roer L; Hansen F; Hasman H; Hammerum AM; Cavaco LM
    Int J Antimicrob Agents; 2020 Jul; 56(1):106041. PubMed ID: 32479890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic
    Shaik S; Ranjan A; Tiwari SK; Hussain A; Nandanwar N; Kumar N; Jadhav S; Semmler T; Baddam R; Islam MA; Alam M; Wieler LH; Watanabe H; Ahmed N
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066550
    [No Abstract]   [Full Text] [Related]  

  • 4. Population snapshot of the extended-spectrum β-lactamase-producing Escherichia coli invasive strains isolated from a Hungarian hospital.
    Tóth K; Tóth Á; Kamotsay K; Németh V; Szabó D
    Ann Clin Microbiol Antimicrob; 2022 Feb; 21(1):3. PubMed ID: 35144632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloodstream infection with extended-spectrum beta-lactamase-producing Escherichia coli: The role of virulence genes.
    Hung WT; Cheng MF; Tseng FC; Chen YS; Shin-Jung Lee S; Chang TH; Lin HH; Hung CH; Wang JL
    J Microbiol Immunol Infect; 2019 Dec; 52(6):947-955. PubMed ID: 31076319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates.
    Rodríguez I; Figueiredo AS; Sousa M; Aracil-Gisbert S; Fernández-de-Bobadilla MD; Lanza VF; Rodríguez C; Zamora J; Loza E; Mingo P; Brooks CJ; Cantón R; Baquero F; Coque TM
    mSphere; 2021 Dec; 6(6):e0086821. PubMed ID: 34935444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Prevalence of ST131 Subclades C2-
    Flament-Simon SC; García V; Duprilot M; Mayer N; Alonso MP; García-Meniño I; Blanco JE; Blanco M; Nicolas-Chanoine MH; Blanco J
    Front Cell Infect Microbiol; 2020; 10():125. PubMed ID: 32266173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
    Kim YA; Lee K; Chung JE
    BMC Infect Dis; 2018 Jun; 18(1):250. PubMed ID: 29859045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Enteroaggregative Escherichia coli within the ST131 Lineage as a Cause of Extraintestinal Infections.
    Boll EJ; Overballe-Petersen S; Hasman H; Roer L; Ng K; Scheutz F; Hammerum AM; Dungu A; Hansen F; Johannesen TB; Johnson A; Nair DT; Lilje B; Hansen DS; Krogfelt KA; Johnson TJ; Price LB; Johnson JR; Struve C; Olesen B; Stegger M
    mBio; 2020 May; 11(3):. PubMed ID: 32430467
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes.
    Irenge LM; Ambroise J; Bearzatto B; Durant JF; Chirimwami RB; Gala JL
    BMC Infect Dis; 2019 Feb; 19(1):137. PubMed ID: 30744567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity, Virulence, and Clinical Significance of Extended-Spectrum β-Lactamase- and pAmpC-Producing
    Bortolami A; Zendri F; Maciuca EI; Wattret A; Ellis C; Schmidt V; Pinchbeck G; Timofte D
    Front Microbiol; 2019; 10():1260. PubMed ID: 31231344
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative Genomics of
    Ranjan A; Shaik S; Nandanwar N; Hussain A; Tiwari SK; Semmler T; Jadhav S; Wieler LH; Alam M; Colwell RR; Ahmed N
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811343
    [No Abstract]   [Full Text] [Related]  

  • 14. First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from Germany.
    Valenza G; Werner M; Eisenberger D; Nickel S; Lehner-Reindl V; Höller C; Bogdan C
    J Glob Antimicrob Resist; 2019 Jun; 17():305-308. PubMed ID: 30682563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and molecular characterization of extended-spectrum β-lactamase (ESBL) and plasmidic AmpC β-lactamase (pAmpC) producing Escherichia coli in dogs.
    Aslantaş Ö; Yilmaz EŞ
    J Vet Med Sci; 2017 Jun; 79(6):1024-1030. PubMed ID: 28450661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?
    Ewers C; Bethe A; Stamm I; Grobbel M; Kopp PA; Guerra B; Stubbe M; Doi Y; Zong Z; Kola A; Schaufler K; Semmler T; Fruth A; Wieler LH; Guenther S
    J Antimicrob Chemother; 2014 May; 69(5):1224-30. PubMed ID: 24398338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.
    Birgy A; Levy C; Nicolas-Chanoine MH; Cointe A; Hobson CA; Magnan M; Bechet S; Bidet P; Cohen R; Bonacorsi S
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-
    Kanamori H; Parobek CM; Juliano JJ; Johnson JR; Johnston BD; Johnson TJ; Weber DJ; Rutala WA; Anderson DJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584139
    [No Abstract]   [Full Text] [Related]  

  • 20. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.
    Estaleva CEL; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Simonsen GS; Haldorsen B; Essack SY; Sundsfjord A
    BMC Infect Dis; 2021 Jan; 21(1):16. PubMed ID: 33407206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.